NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/05/2025
Back to search
Official data from USPTO
PAIRXBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
08/05/2025
Trademark type
Word
Nice classes
5, 42
Filing date
09/19/2024
Registration date
08/05/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/05/2025
Last transaction
08/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
24
Owner location
Singapore, SG
Examiner
SORIANO, JASMINE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PairX Bio Pte. Ltd.
Representatives
James L. Scott Privus PLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological and pharmaceutical preparations for treatment of inflammation and immunology disorders; biological and pharmaceutical preparationsbi-specificsmulti specificsT-cell engagersradioligands and small molecules; Diagnostic preparations for medical purposes; biological and pharmaceutical preparations for treatment of cancer and tumors; human therapeutic vaccine preparations for use in oncology; anti-cancer preparations; therapeutic preparations being solutionsantigensantibodiesantibody-drug conjugates; T-cells in the nature of preparations for treatment of cancer and tumors; diagnostic preparations for medical purposesantigensantibodiescells for therapeutic use; medical preparationsvaccinesantigensimmunotherapeutic agents for the treatment and prevention of cancers and tumors
Class 42
Scientific research services for medical purposes; scientific research services for medical purposes in the field of oncology; immunotherapy research; design and development of therapeutic vaccinesimmunotherapy and pharmaceutical products; design and development of therapeutic products in oncology; research and development of antigenic and immunotherapeutic agents; research and development in the field of mRNA technology; research and development in the field of therapeutics; providing medical and scientific research informationdesigning algorithms and models for use in scientific and medical research; providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cellsantigenstissuesgene expressionsgene sequencesgenome annotationsantigen characteristics and immunological responses; providing temporary use of an online non-downloadable computer software platform featuring algorithms for predicting the characteristics of antigens and immunological responses; providing temporary use of an online non-downloadable computer software platform for research and development in the field of therapeutics; platform as a service (paas) featuring computer software platforms for accessingcollectingdetectingcomparingcalculatinganalyzingdisplayingtransmittingmanaging and storing RNA sequencing and other multi-omic data; providing temporary use of online non-downloadable computer software for use in data collectionreviewinterpretationcomparisonanalysis of T cells and/or other immune cells features
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/17/2025
PUBO
PUBLISHED FOR OPPOSITION
06/17/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/15/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2025
ALIE
ASSIGNED TO LIE
05/06/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/28/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/23/2025
GNSL
LETTER OF SUSPENSION E-MAILED
03/23/2025
CNSL
SUSPENSION LETTER WRITTEN
03/23/2025
DOCK
ASSIGNED TO EXAMINER
03/17/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/19/2024
NWAP
NEW APPLICATION ENTERED
09/19/2024
Continuous trademark protection
Get notified about every new filing that threatens PAIRXBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.